NeuroSense Therapeutics
NRSN
NRSN
5 hedge funds and large institutions have $41.6K invested in NeuroSense Therapeutics in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$4.96K |
Top Sellers
| 1 |
1
Renaissance Technologies
New York
|
$22K |
| 2 |
VPIM
2
Vanguard Personalized Indexing Management
Oakland,
California
|
$13.7K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $22K | -$42.8K | -35,867 | -66% |
|
|
VPIM
2
Vanguard Personalized Indexing Management
Oakland,
California
| $13.7K | -$6.52K | -5,340 | -32% |
|
|
3
UBS Group
Zurich,
Switzerland
| $4.96K | +$2.73K | +2,238 | +122% |
|
4
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $1K | – | – | – |
|
5
Morgan Stanley
New York
| $5 | – | – | – |
|